| Ticker Details |
Laboratory Corporation of America Holdings
Laboratory Corp of America Holdings is a healthcare diagnostics company. It is engaged in providing comprehensive clinical laboratory and end-to-end drug development services. It operates in two segments: LabCorp Diagnostics and Covance Drug Development.
|
| IPO Date: |
May 9, 1995 |
| Sector: |
Healthcare |
| Industry: |
Health Care Providers and Services |
| Market Cap: |
$27.28B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.35 | 0.94%
|
| Avg Daily Range (30 D): |
$4.53 | 1.50%
|
| Avg Daily Range (90 D): |
$3.47 | 1.24%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.79M |
| Avg Daily Volume (30 D): |
.56M |
| Avg Daily Volume (90 D): |
.5M |
| Trade Size |
| Avg Trade Size (Sh.): |
87 |
| Avg Trade Size (Sh.) (30 D): |
25 |
| Avg Trade Size (Sh.) (90 D): |
23 |
| Institutional Trades |
| Total Institutional Trades: |
19,669 |
| Avg Institutional Trade: |
$5.48M |
| Avg Institutional Trade (30 D): |
$25.74M |
| Avg Institutional Trade (90 D): |
$23.62M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$13.65M |
| Avg Closing Trade (30 D): |
$39.06M |
| Avg Closing Trade (90 D): |
$39.32M |
| Avg Closing Volume: |
74.22K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$12.17
|
$3.66
|
$3.37
|
|
Diluted EPS
|
$12.09
|
$3.64
|
$3.35
|
|
Revenue
|
$14.35B
|
$3.73B
|
$3.54B
|
|
Gross Profit
|
$4.14B
|
$1.11B
|
$1.01B
|
|
Net Income / Loss
|
$1B
|
$299.1M
|
$278M
|
|
Operating Income / Loss
|
$1.5B
|
$451.6M
|
$380.8M
|
|
Cost of Revenue
|
$10.2B
|
$2.62B
|
$2.52B
|
|
Net Cash Flow
|
$-479M
|
$-840.6M
|
$449.9M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jul 03, 2023
|
1164:1000
|
|
May 13, 2002
|
2:1
|
|
Jun 12, 2001
|
2:1
|
|
May 04, 2000
|
1:10
|
|
|
|
